Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
International Journal of Oncology
|
March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer
A Riccardi, C Tinelli, S Brugnatelli, et al.
Physical Review Letters
|
November 19, 2021
Phase Diagram for Light-Induced Superconductivity in κ-(ET)_{2}-X
M Buzzi, D Nicoletti, S Fava, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group
E Bajetta, R Buzzoni, L Mariani, et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina
|
January 8, 2000
Perioperative frozen section examination in parotid gland tumors
M B Carvalho, J M Soares, A Rapoport, et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina
|
September 1, 1995
The value of therapeutic planning and the degree of experience of the surgical team on the results of cancer treatment of the larynx and hypopharynx
M B de Carvalho, A Rapoport, A S Fava, et al.
Anticancer Research
|
August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study
S Barni, M Visini, E Piazza, et al.
British Journal of Cancer
|
July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
A Riccardi, P Pugliese, M Danova, et al.
Medical and Pediatric Oncology
|
July 29, 1998
Head and neck squamous cell carcinoma in childhood
M B de Carvalho, J de A Sobrinho, A Rapoport, et al.
Tumori
|
December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer
A Riccardi, S Brugnatelli, M Giordano, et al.
Pathogens (Basel, Switzerland)
|
February 23, 2024
Antifungal Resistance in Cryptococcal Infections
Marcia S C Melhem, Diniz Pereira Leite Júnior, Juliana P F Takahashi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
International Journal of Oncology
|
March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer
A Riccardi, C Tinelli, S Brugnatelli, et al.
Physical Review Letters
|
November 19, 2021
Phase Diagram for Light-Induced Superconductivity in κ-(ET)_{2}-X
M Buzzi, D Nicoletti, S Fava, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group
E Bajetta, R Buzzoni, L Mariani, et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina
|
January 8, 2000
Perioperative frozen section examination in parotid gland tumors
M B Carvalho, J M Soares, A Rapoport, et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina
|
September 1, 1995
The value of therapeutic planning and the degree of experience of the surgical team on the results of cancer treatment of the larynx and hypopharynx
M B de Carvalho, A Rapoport, A S Fava, et al.
Anticancer Research
|
August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study
S Barni, M Visini, E Piazza, et al.
British Journal of Cancer
|
July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
A Riccardi, P Pugliese, M Danova, et al.
Medical and Pediatric Oncology
|
July 29, 1998
Head and neck squamous cell carcinoma in childhood
M B de Carvalho, J de A Sobrinho, A Rapoport, et al.
Tumori
|
December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer
A Riccardi, S Brugnatelli, M Giordano, et al.
Pathogens (Basel, Switzerland)
|
February 23, 2024
Antifungal Resistance in Cryptococcal Infections
Marcia S C Melhem, Diniz Pereira Leite Júnior, Juliana P F Takahashi, et al.
Page
of 7